サマリー

エグゼクティブサマリー

世界の急性片頭痛薬市場は、2021年に84億米ドル規模に達し、2023年から2028年にかけて7.82%のCAGRで拡大すると予測されています。労働人口の片頭痛有病率の上昇と医療費の増加が、急性片頭痛薬の需要を押し上げています。

トリプタンは、選択的セロトニン受容体アゴニストであるため、片頭痛治療薬として広く使用されています。脳内のセロトニン濃度を高めることで、炎症を抑え、血管を収縮させ、頭痛や片頭痛を終わらせる効果があります。2021年の薬物タイプ別市場シェアでは、トリプタン系薬剤が全体の約46%を占めています。片頭痛の軽い痛みの治療には、ナプロキセン、イブプロフェン、アスピリン、アセトアミノフェン、プソイドエフェドリン、フェニレフリンなどの市販薬が広く利用されている。

片頭痛に悩む患者やトリプタンの限界から、急性片頭痛の治療には大きな可能性があります。このシナリオでは、Ubrelvy、Reyvow、Nurtec ODTを含む多くの新規治療オプションが存在します。しかし、大きく前進している治療法の1つが、Impel社のTrudhesaで、DHEを経鼻投与するための自己投与型薬剤装置です。Trudhesaは2021年9月にFDAの承認を得ています。

片頭痛の症例の約4分の3は女性が占めています。20歳から45歳の女性が最も片頭痛に悩まされやすいと言われています。さらに、女性のホルモン変動が片頭痛の引き金になることもあり、月経時片頭痛は女性の片頭痛患者の約60％に影響を与えています。2021年の市場規模では、米州が金額ベースで大きなシェアを占めており、同地域は急性片頭痛薬の売上全体でも最大のシェアを維持し続けると予想されます。



本レポートの対象範囲

- 本レポートは、急性片頭痛薬市場を金額（USD Billion）別に分析しています。

- 本レポートでは、2018-2021年の過去期間、2022年の基準年、2023-2028年の予測期間における急性片頭痛薬市場の分析を紹介します。

- 急性片頭痛薬市場を薬剤タイプ（エルゴアルカロイド、鎮痛剤、トリプタン、香料、その他の薬剤タイプ）別に分析したレポートです。

- 急性片頭痛薬市場を投与経路別（静脈内投与、経口投与、経鼻投与、その他の投与経路）に分析した報告書です。

- 急性偏頭痛治療薬の市場を入手可能性（Over the Counter、Prescription）別に分析しています。

- 急性偏頭痛治療薬の世界市場を国別（米国、カナダ、ドイツ、英国、フランス、イタリア、スペイン、中国、日本、インド）に分析したレポートです。

- 本レポートの主要なインサイトは、SWOTおよびポーターのファイブフォース分析のフレームワークを通じて提示されています。また、市場の魅力は、地域別、薬剤タイプ別、利用可能性別に提示されています。

- また、業界の主要な機会、トレンド、ドライバー、課題についても分析されています。

- 競合他社の動向、戦略、M&A、新製品開発などを追跡しています。本レポートに掲載されている企業は、イーライリリー・アンド・カンパニー、GSK plc.、バイエルAG、ジョンソン・エンド・ジョンソン、テバ・ファーマスーティカル・インダストリーズ・リミテッド、AbbVie Inc.、ノバルティス、メルク・アンド・カンパニー、ファイザー、ベーリンガー・インゲルハイム、です。



主なターゲットオーディエンス

- 医療・製薬企業

- エピソード型片頭痛患者

- 主要な急性片頭痛薬ブランド

- 研究開発機関

ページTOPに戻る

目次

1. Market Background

1.1 Scope and Product Outlook

1.2 Executive Summary

1.3 Research Methodology



2. Strategic Recommendations



3. Global Acute Migraine Drugs Market: Historic and Forecast (2018-2028)

3.1 Impact Analysis of Macro Economic Factors on Acute Migraine Drugs Market

3.2 Global Acute Migraine Drugs Market: Ecosystem Analysis

3.2.1 Migraine: Fact sheet

3.2.2 Migraine – Nurtec ODT and Ubrelvy patient’s Therapy abandonment data

3.2.3 Pipeline scenario of Acute Migraine Drugs

3.2.4 Annual Sales of Triptans and Non Triptans in the U.S

3.3 Global Acute Migraine Drugs Market: Dashboard

3.4 Global Acute Migraine Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)

3.5 Impact of COVID-19 on Acute Migraine Drugs Market

3.6 Global Acute Migraine Drugs Market Segmentation: By Drug Type (2018-2028)

3.6.1 Global Acute Migraine Drugs Market, By Drug Type Overview

3.6.2 Global Acute Migraine Drugs Market Size, By Ergot Alkaloids, By Value, 2018H-2028F (USD Billion & CAGR)

3.6.3 Global Acute Migraine Drugs Market Size, By Analgesics, By Value, 2018H-2028F (USD Billion & CAGR)

3.6.4 Global Acute Migraine Drugs Market Size, By Triptans, By Value, 2018H-2028F (USD Billion & CAGR)

3.6.5 Global Acute Migraine Drugs Market Size, By Other Drug Types, By Value, 2018H-2028F (USD Billion & CAGR)

3.7 Global Acute Migraine Drugs Market Segmentation: By Route of Administration

3.7.1 Global Acute Migraine Drugs Market, By Route of Administration Overview

3.7.2 Global Acute Migraine Drugs Market Size, By Intravenous, By Value, 2018H-2028F (USD Billion & CAGR)

3.7.3 Global Acute Migraine Drugs Market Size, By Oral, By Value, 2018H-2028F (USD Billion & CAGR)

3.7.4 Global Acute Migraine Drugs Market Size, By Nasal, By Value, 2018H-2028F (USD Billion & CAGR)

3.7.5 Global Acute Migraine Drugs Market Size, By Other Routes of Administration, By Value, 2018H-2028F (USD Billion & CAGR)

3.8 Global Acute Migraine Drugs Market Segmentation: By Availability

3.8.1 Global Acute Migraine Drugs Market, By Availability Overview

3.8.2 Global Acute Migraine Drugs Market Size, By Over The Counter, By Value, 2018H-2028F (USD Billion & CAGR)

3.8.3 Global Acute Migraine Drugs Market Size, By Prescription, By Value, 2018H-2028F (USD Billion & CAGR)



4. Global Acute Migraine Drugs Market, Regional Analysis (2018-2028)

4.1 Regional Coverage of the Study

4.2 Regional Snapshot



5. Americas Acute Migraine Drugs Market: Historic and Forecast (2018-2028)

5.1 Americas Acute Migraine Drugs Market: Snapshot

5.2 Americas Acute Migraine Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)

5.3 Americas Acute Migraine Drugs Market: Key Factors

5.4 Americas Acute Migraine Drugs Market Segmentation: By Drug Type

5.4.1 Americas Acute Migraine Drugs Market, By Drug Type Overview

5.4.2 Americas Acute Migraine Drugs Market Size, By Ergot Alkaloids, By Value, 2018H-2028F (USD Billion & CAGR)

5.4.3 Americas Acute Migraine Drugs Market Size, By Analgesics, By Value, 2018H-2028F (USD Billion & CAGR)

5.4.4 Americas Acute Migraine Drugs Market Size, By Triptans, By Value, 2018H-2028F (USD Billion & CAGR)

5.4.5 Americas Acute Migraine Drugs Market Size, By Other Drug Types, By Value, 2018H-2028F (USD Billion & CAGR)

5.5 Americas Acute Migraine Drugs Market Segmentation: By Route of Administration

5.5.1 Americas Acute Migraine Drugs Market, By Route of Administration Overview

5.5.2 Americas Acute Migraine Drugs Market Size, By Intravenous, By Value, 2018H-2028F (USD Billion & CAGR)

5.5.3 Americas Acute Migraine Drugs Market Size, By Oral, By Value, 2018H-2028F (USD Billion & CAGR)

5.5.4 Americas Acute Migraine Drugs Market Size, By Nasal, By Value, 2018H-2028F (USD Billion & CAGR)

5.5.5 Americas Acute Migraine Drugs Market Size, By Other Routes of Administration, By Value, 2018H-2028F (USD Billion & CAGR)

5.6 Americas Acute Migraine Drugs Market Segmentation: By Availability

5.6.1 Americas Acute Migraine Drugs Market, By Availability Overview

5.6.2 Americas Acute Migraine Drugs Market Size, By By Over The Counter, By Value, 2018H-2028F (USD Billion & CAGR)

5.6.3 Americas Acute Migraine Drugs Market Size, By Prescription, By Value, 2018H-2028F (USD Billion & CAGR)

5.7 Americas Acute Migraine Drugs Market Segmentation: By Country

5.7.1 Americas Acute Migraine Drugs Market Segmentation, By Country Overview

5.7.2 United States Acute Migraine Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)

5.7.2.1 United States Acute Migraine Drugs Market, By Drug Type

5.7.2.2 United States Acute Migraine Drugs Market, By Route of Administration

5.7.2.3 United States Acute Migraine Drugs Market, By Availability

5.7.3 Canada Acute Migraine Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)

5.7.3.1 Canada Acute Migraine Drugs Market, By Drug Type

5.7.3.2 Canada Acute Migraine Drugs Market, By Route of Administration

5.7.3.3 Canada Acute Migraine Drugs Market, By Availability

5.7.4 Rest of Americas Acute Migraine Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)

5.7.4.1 Rest of Americas Acute Migraine Drugs Market, By Drug Type

5.7.4.2 Rest of Americas Acute Migraine Drugs Market, By Route of Administration

5.7.4.3 Rest of Americas Acute Migraine Drugs Market, By Availability



6. Europe Acute Migraine Drugs Market: Historic and Forecast (2018-2028)

6.1 Europe Acute Migraine Drugs Market: Snapshot

6.2 Europe Acute Migraine Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)

6.3 Europe Acute Migraine Drugs Market: Key Factors

6.4 Europe Acute Migraine Drugs Market Segmentation: By Drug Type

6.4.1 Europe Acute Migraine Drugs Market, By Drug Type Overview

6.4.2 Europe Acute Migraine Drugs Market Size, By Ergot Alkaloids, By Value, 2018H-2028F (USD Billion & CAGR)

6.4.3 Europe Acute Migraine Drugs Market Size, By Analgesics, By Value, 2018H-2028F (USD Billion & CAGR)

6.4.4 Europe Acute Migraine Drugs Market Size, By Triptans, By Value, 2018H-2028F (USD Billion & CAGR)

6.4.5 Europe Acute Migraine Drugs Market Size, By Other Drug Types, By Value, 2018H-2028F (USD Billion & CAGR)

6.5 Europe Acute Migraine Drugs Market Segmentation: By Route of Administration

6.5.1 Europe Acute Migraine Drugs Market, By Route of Administration Overview

6.5.2 Europe Acute Migraine Drugs Market Size, By Intravenous, By Value, 2018H-2028F (USD Billion & CAGR)

6.5.3 Europe Acute Migraine Drugs Market Size, By Oral, By Value, 2018H-2028F (USD Billion & CAGR)

6.5.4 Europe Acute Migraine Drugs Market Size, By Nasal, By Value, 2018H-2028F (USD Billion & CAGR)

6.5.5 Europe Acute Migraine Drugs Market Size, By Other Routes of Administration, By Value, 2018H-2028F (USD Billion & CAGR)

6.6 Europe Acute Migraine Drugs Market Segmentation: By Availability

6.6.1 Europe Acute Migraine Drugs Market, By Availability Overview

6.6.2 Europe Acute Migraine Drugs Market Size, By By Over The Counter, By Value, 2018H-2028F (USD Billion & CAGR)

6.6.3 Europe Acute Migraine Drugs Market Size, By Prescription, By Value, 2018H-2028F (USD Billion & CAGR)

6.7 Europe Acute Migraine Drugs Market Segmentation: By Country

6.7.1 Europe Acute Migraine Drugs Market Segmentation, By Country, Overview

6.7.2 Germany Acute Migraine Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)

6.7.2.1 Germany Acute Migraine Drugs Market, By Drug Type

6.7.2.2 Germany Acute Migraine Drugs Market, By Route of Administration

6.7.2.3 Germany Acute Migraine Drugs Market, By Availability

6.7.3 United Kingdom Acute Migraine Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)

6.7.3.1 United Kingdom Acute Migraine Drugs Market, By Drug Type

6.7.3.2 United Kingdom Acute Migraine Drugs Market, By Route of Administration

6.7.3.3 United Kingdom Acute Migraine Drugs Market, By Availability

6.7.4 France Acute Migraine Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)

6.7.4.1 France Acute Migraine Drugs Market, By Drug Type

6.7.4.2 France Acute Migraine Drugs Market, By Route of Administration

6.7.4.3 France Acute Migraine Drugs Market, By Availability

6.7.5 Italy Acute Migraine Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)

6.7.5.1 Italy Acute Migraine Drugs Market, By Drug Type

6.7.5.2 Italy Acute Migraine Drugs Market, By Route of Administration

6.7.5.3 Italy Acute Migraine Drugs Market, By Availability

6.7.6 Spain Acute Migraine Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)

6.7.6.1 Spain Acute Migraine Drugs Market, By Drug Type

6.7.6.2 Spain Acute Migraine Drugs Market, By Route of Administration

6.7.6.3 Spain Acute Migraine Drugs Market, By Availability

6.7.7 Rest of Europe Acute Migraine Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)

6.7.7.1 Rest of Europe Acute Migraine Drugs Market, By Drug Type

6.7.7.2 Rest of Europe Acute Migraine Drugs Market, By Route of Administration

6.7.7.3 Rest of Europe Acute Migraine Drugs Market, By Availability



7. Asia Pacific Acute Migraine Drugs Market: Historic and Forecast (2018-2028)

7.1 Asia Pacific Acute Migraine Drugs Market: Snapshot

7.2 Asia Pacific Acute Migraine Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)

7.3 Asia Pacific Acute Migraine Drugs Market: Key Factors

7.4 Asia Pacific Acute Migraine Drugs Market Segmentation: By Drug Type

7.4.1 Asia Pacific Acute Migraine Drugs Market, By Drug Type Overview

7.4.2 Asia Pacific Acute Migraine Drugs Market Size, By Ergot Alkaloids, By Value, 2018H-2028F (USD Billion & CAGR)

7.4.3 Asia Pacific Acute Migraine Drugs Market Size, By Analgesics, By Value, 2018H-2028F (USD Billion & CAGR)

7.4.4 Asia Pacific Acute Migraine Drugs Market Size, By Triptans, By Value, 2018H-2028F (USD Billion & CAGR)

7.4.5 Asia Pacific Acute Migraine Drugs Market Size, By Other Drug Types, By Value, 2018H-2028F (USD Billion & CAGR)

7.5 Asia Pacific Acute Migraine Drugs Market Segmentation: By Route of Administration

7.5.1 Asia Pacific Acute Migraine Drugs Market, By Route of Administration Overview

7.5.2 Asia Pacific Acute Migraine Drugs Market Size, By Intravenous, By Value, 2018H-2028F (USD Billion & CAGR)

7.5.3 Asia Pacific Acute Migraine Drugs Market Size, By Oral, By Value, 2018H-2028F (USD Billion & CAGR)

7.5.4 Asia Pacific Acute Migraine Drugs Market Size, By Nasal, By Value, 2018H-2028F (USD Billion & CAGR)

7.5.5 Asia Pacific Acute Migraine Drugs Market Size, By Other Routes of Administration, By Value, 2018H-2028F (USD Billion & CAGR)

7.6 Asia Pacific Acute Migraine Drugs Market Segmentation: By Availability

7.6.1 Asia Pacific Acute Migraine Drugs Market, By Availability Overview

7.6.2 Asia Pacific Acute Migraine Drugs Market Size, By Over the Counter, By Value, 2018H-2028F (USD Billion & CAGR)

7.6.3 Asia Pacific Acute Migraine Drugs Market Size, By Prescription, By Value, 2018H-2028F (USD Billion & CAGR)

7.7 Asia Pacific Acute Migraine Drugs Market Segmentation: By Country

7.7.1 Asia Pacific Acute Migraine Drugs Market, By Country Overview

7.7.2 China Acute Migraine Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)

7.7.2.1 China Acute Migraine Drugs Market, By Drug Type

7.7.2.2 China Acute Migraine Drugs Market, By Route of Administration

7.7.2.3 China Acute Migraine Drugs Market, By Availability

7.7.3 Japan Acute Migraine Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)

7.7.3.1 Japan Acute Migraine Drugs Market, By Drug Type

7.7.3.2 Japan Acute Migraine Drugs Market, By Route of Administration

7.7.3.3 Japan Acute Migraine Drugs Market, By Availability

7.7.4 India Acute Migraine Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)

7.7.4.1 India Acute Migraine Drugs Market, By Drug Type

7.7.4.2 India Acute Migraine Drugs Market, By Route of Administration

7.7.4.3 India Acute Migraine Drugs Market, By Availability

7.7.5 Rest Of Asia Pacific Acute Migraine Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)

7.7.5.1 Rest Of Asia Pacific Acute Migraine Drugs Market, By Drug Type

7.7.5.2 Rest Of Asia Pacific Acute Migraine Drugs Market, By Route of Administration

7.7.5.3 Rest Of Asia Pacific Acute Migraine Drugs Market, By Availability



8. Middle East & Africa Acute Migraine Drugs Market: Historic and Forecast (2018-2028)

8.1 Middle East & Africa Acute Migraine Drugs Market: Snapshot

8.2 Middle East & Africa Acute Migraine Drugs Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)

8.3 Middle East & Africa Acute Migraine Drugs Market: Key Factors

8.4 Middle East & Africa Acute Migraine Drugs Market Segmentation: By Drug Type

8.4.1 Middle East & Africa Acute Migraine Drugs Market, By Drug Type Overview

8.4.2 Middle East & Africa Acute Migraine Drugs Market Size, By Ergot Alkaloids, By Value, 2018H-2028F (USD Billion & CAGR)

8.4.3 Middle East & Africa Acute Migraine Drugs Market Size, By Analgesics, By Value, 2018H-2028F (USD Billion & CAGR)

8.4.4 Middle East & Africa Acute Migraine Drugs Market Size, By Triptans, By Value, 2018H-2028F (USD Billion & CAGR)

8.4.5 Middle East & Africa Acute Migraine Drugs Market Size, By Other Drug Types, By Value, 2018H-2028F (USD Billion & CAGR)

8.5 Middle East & Africa Acute Migraine Drugs Market Segmentation: By Route of Administration

8.5.1 Middle East & Africa Acute Migraine Drugs Market, By Route of Administration Overview

8.5.1 Middle East & Africa Acute Migraine Drugs Market Size, By Intravenous, By Value, 2018H-2028F (USD Billion & CAGR)

8.5.1 Middle East & Africa Acute Migraine Drugs Market Size, By Oral, By Value, 2018H-2028F (USD Billion & CAGR)

8.5.1 Middle East & Africa Acute Migraine Drugs Market Size, By Nasal, By Value, 2018H-2028F (USD Billion & CAGR)

8.5.1 Middle East & Africa Acute Migraine Drugs Market Size, By Other Routes of Administration, By Value, 2018H-2028F (USD Billion & CAGR)

8.6 Middle East & Africa Acute Migraine Drugs Market Segmentation: By Availability

8.6.1 Middle East & Africa Acute Migraine Drugs Market, By Availability Overview

8.6.2 Middle East & Africa Acute Migraine Drugs Market Size, By Over the Counter, By Value, 2018H-2028F (USD Billion & CAGR)

8.6.3 Middle East & Africa Acute Migraine Drugs Market Size, By Prescription, By Value, 2018H-2028F (USD Billion & CAGR)



9. Market Dynamics

9.1 Impact assessment of Market Dynamics on Global Acute Migraine Drugs Market

9.2 Drivers

9.3 Restraints

9.4 Trends



10. Industry Ecosystem Analysis

10.1 Macro-Economic Factor Assessment

10.2 Value Chain Analysis

10.3 Porter’s Five Forces Model



11. Competitive Positioning

11.1 Companies’ Product Positioning

11.2 Market Position Matrix

11.3 Market Share Analysis of Acute Migraine Drugs Market

11.4 Company Profiles

11.4.1 Eli Lilly and Company

11.4.2 GSK plc.

11.4.3 Bayer AG

11.4.4 Johnson & Johnson

11.4.5 Teva Pharmaceutical Industries Ltd.

11.4.6 AbbVie Inc.

11.4.7 Novartis

11.4.8 Merck & Co., Inc.

11.4.9 Pfizer Inc.

11.4.10 Boehringer Ingelheim

12. About Us & Disclaimer

ページTOPに戻る

図表リスト

List of Figures

Figure 1: Migraine – Nurtec ODT and Ubrelvy patient’s Therapy abandonment data

Figure 2: Migraine – Annual Sales of Triptans and Non-Triptans in the U.S

Figure 3: Global Acute Migraine Drugs Market Size, By Value, 2018-2021 (USD Billion)

Figure 4: Global Acute Migraine Drugs Market Size, By Value, 2022-2028 (USD Billion)

Figure 5: Global Acute Migraine Drugs Market Share, By Drug Type, 2021 (%)

Figure 6: Global Acute Migraine Drugs Market Size, By Ergot Alkaloids, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 7: Global Acute Migraine Drugs Market Absolute Opportunity, By Ergot Alkaloids, 2018-2028 (USD Billion)

Figure 8: Global Acute Migraine Drugs Market Size, By Analgesics, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 9: Global Acute Migraine Drugs Market Absolute Opportunity, By Analgesics, 2018-2028 (USD Billion)

Figure 10: Global Acute Migraine Drugs Market Size, By Triptans, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 11: Global Acute Migraine Drugs Market Absolute Opportunity, By Triptans, 2018-2028 (USD Billion)

Figure 12: Global Acute Migraine Drugs Market Size, By Other Drug Types, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 13: Global Acute Migraine Drugs Market Absolute Opportunity, By Other Drug Types, 2018-2028 (USD Billion)

Figure 14: Global Acute Migraine Drugs Market Size, By Intravenous, By Value, 2018H--2028F (USD Billion & CAGR)

Figure 15: Global Acute Migraine Drugs Market Absolute Opportunity, By Intravenous, 2018-2028 (USD Billion)

Figure 16: Global Acute Migraine Drugs Market Size, By Oral, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 17: Global Acute Migraine Drugs Market Absolute Opportunity, By Oral, 2018-2028 (USD Billion)

Figure 18: Global Acute Migraine Drugs Market Size, By Nasal, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 19: Global Acute Migraine Drugs Market Absolute Opportunity, By Nasal, 2018-2028 (USD Billion)

Figure 20: Global Acute Migraine Drugs Market Size, By Other Routes of Administration, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 21: Global Acute Migraine Drugs Market Absolute Opportunity, By Other Routes of Administration, 2018-2028 (USD Billion)

Figure 22: Global Acute Migraine Drugs Market Size, By Over The Counter, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 23: Global Acute Migraine Drugs Market Absolute Opportunity, By Over The Counter, 2018-2028 (USD Billion)

Figure 24: Global Acute Migraine Drugs Market Size, By Prescription, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 25: Global Acute Migraine Drugs Market Absolute Opportunity, By Prescription, 2018-2028 (USD Billion)

Figure 26: Americas Acute Migraine Drugs Market Size, By Value, 2018H-2028F (USD Billion)

Figure 27: Americas Acute Migraine Drugs Market Share, By Drug Type, 2021 (%)

Figure 28: Americas Acute Migraine Drugs Market, By Ergot Alkaloids, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 29: Americas Acute Migraine Drugs Market, By Analgesics, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 30: Americas Acute Migraine Drugs Market, By Triptans, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 31: Americas Acute Migraine Drugs Market, By Other Drug Types, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 32: Americas Acute Migraine Drugs Market, By Intravenous, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 33: Americas Acute Migraine Drugs Market, By Oral, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 34: Americas Acute Migraine Drugs Market, By Nasal, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 35: Americas Acute Migraine Drugs Market, By Other Routes of Administration, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 36: Americas Acute Migraine Drugs Market, By Over The Counter Availability, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 37: Americas Acute Migraine Drugs Market, By Prescription Availability, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 38: United States Acute Migraine Drugs Market, By Value, 2018-2028 (USD Billion & CAGR)

Figure 39: United States Acute Migraine Drugs Market Value, By Drug Type, 2021 (USD Billion)

Figure 40: United States Acute Migraine Drugs Market Share, By Drug Type, By Value, 2021 (%)

Figure 41: United States Acute Migraine Drugs Market Share, By Route of Administration, By Value, 2021 (%)

Figure 42: United States Acute Migraine Drugs Market Share, By Availability, By Value, 2021 (%)

Figure 43: Canada Acute Migraine Drugs Market, By Value, 2018-2028 (USD Billion & CAGR)

Figure 44: Canada Acute Migraine Drugs Market Value, By Drug Type, 2021 (USD Billion)

Figure 45: Canada Acute Migraine Drugs Market Share, By Drug Type, By Value, 2021 (%)

Figure 46: Canada Acute Migraine Drugs Market Share, By Route of Administration, By Value, 2021 (%)

Figure 47: Canada Acute Migraine Drugs Market Share, By Availability, By Value, 2021 (%)

Figure 48: Rest of Americas Acute Migraine Drugs Market, By Value, 2018-2028 (USD Billion & CAGR)

Figure 49: Rest of Americas Acute Migraine Drugs Market Value, By Drug Type, 2021 (USD Billion)

Figure 50: Rest of Americas Acute Migraine Drugs Market Share, By Drug Type, By Value, 2021 (%)

Figure 51: Rest of Americas Acute Migraine Drugs Market Share, By Route of Administration, By Value, 2021 (%)

Figure 52: Rest of Americas Acute Migraine Drugs Market Share, By Availability, By Value, 2021 (%)

Figure 53: Europe Acute Migraine Drugs Market Size, By Value, 2018H-2028F (USD Billion)

Figure 54: Europe Acute Migraine Drugs Market Share, By Drug Type, 2021 (%)

Figure 55: Europe Acute Migraine Drugs Market, By Ergot Alkaloids, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 56: Europe Acute Migraine Drugs Market, By Analgesics, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 57: Europe Acute Migraine Drugs Market, By Triptans, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 58: Europe Acute Migraine Drugs Market, By Other Drug Types, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 59: Europe Acute Migraine Drugs Market, By Intravenous, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 60: Europe Acute Migraine Drugs Market, By Oral, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 61: Europe Acute Migraine Drugs Market, By Nasal, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 62: Europe Acute Migraine Drugs Market, By Other Routes of Administration, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 63: Europe Acute Migraine Drugs Market, By Over The Counter Availability, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 64: Europe Acute Migraine Drugs Market, By Prescription Availability, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 65: Germany Acute Migraine Drugs Market, By Value, 2018-2028 (USD Billion & CAGR)

Figure 66: Germany Acute Migraine Drugs Market Value, By Drug Type, 2021 (USD Billion)

Figure 67: Germany Acute Migraine Drugs Market Share, By Drug Type, By Value, 2021 (%)

Figure 68: Germany Acute Migraine Drugs Market Share, By Route of Administration, By Value, 2021 (%)

Figure 69: Germany Acute Migraine Drugs Market Share, By Availability, By Value, 2021 (%)

Figure 70: United Kingdom Acute Migraine Drugs Market, By Value, 2018-2028 (USD Billion & CAGR)

Figure 71: United Kingdom Acute Migraine Drugs Market Value, By Drug Type, 2021 (USD Billion)

Figure 72: United Kingdom Acute Migraine Drugs Market Share, By Drug Type, By Value, 2021 (%)

Figure 73: United Kingdom Acute Migraine Drugs Market Share, By Route of Administration, By Value, 2021 (%)

Figure 74: United Kingdom Acute Migraine Drugs Market Share, By Availability, By Value, 2021 (%)

Figure 75: France Acute Migraine Drugs Market, By Value, 2018-2028 (USD Billion & CAGR)

Figure 76: France Acute Migraine Drugs Market Value, By Drug Type, 2021 (USD Billion)

Figure 77: France Acute Migraine Drugs Market Share, By Drug Type, By Value, 2021 (%)

Figure 78: France Acute Migraine Drugs Market Share, By Route of Administration, By Value, 2021 (%)

Figure 79: France Acute Migraine Drugs Market Share, By Availability, By Value, 2021 (%)

Figure 80: Italy Acute Migraine Drugs Market, By Value, 2018-2028 (USD Billion & CAGR)

Figure 81: Italy Acute Migraine Drugs Market Value, By Drug Type, 2021 (USD Billion)

Figure 82: Italy Acute Migraine Drugs Market Share, By Drug Type, By Value, 2021 (%)

Figure 83: Italy Acute Migraine Drugs Market Share, By Route of Administration, By Value, 2021 (%)

Figure 84: Italy Acute Migraine Drugs Market Share, By Availability, By Value, 2021 (%)

Figure 85: Spain Acute Migraine Drugs Market, By Value, 2018-2028 (USD Billion & CAGR)

Figure 86: Spain Acute Migraine Drugs Market Value, By Drug Type, 2021 (USD Billion)

Figure 87: Spain Acute Migraine Drugs Market Share, By Drug Type, By Value, 2021 (%)

Figure 88: Spain Acute Migraine Drugs Market Share, By Route of Administration, By Value, 2021 (%)

Figure 89: Spain Acute Migraine Drugs Market Share, By Availability, By Value, 2021 (%)

Figure 90: Rest of Europe Acute Migraine Drugs Market, By Value, 2018-2028 (USD Billion & CAGR)

Figure 91: Rest of Europe Acute Migraine Drugs Market Value, By Drug Type, 2021 (USD Billion)

Figure 92: Rest of Europe Acute Migraine Drugs Market Share, By Drug Type, By Value, 2021 (%)

Figure 93: Rest of Europe Acute Migraine Drugs Market Share, By Route of Administration, By Value, 2021 (%)

Figure 94: Rest of Europe Acute Migraine Drugs Market Share, By Availability, By Value, 2021 (%)

Figure 95: Asia Pacific Acute Migraine Drugs Market Size, By Value, 2018H-2028F (USD Billion)

Figure 96: Asia Pacific Acute Migraine Drugs Market Share, By Drug Type, 2021 (%)

Figure 97: Asia Pacific Acute Migraine Drugs Market, By Ergot Alkaloids, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 98: Asia Pacific Acute Migraine Drugs Market, By Analgesics, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 99: Asia Pacific Acute Migraine Drugs Market, By Triptans, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 100: Asia Pacific Acute Migraine Drugs Market, By Other Drug Types, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 101: Asia Pacific Acute Migraine Drugs Market, By Intravenous, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 102: Asia Pacific Acute Migraine Drugs Market, By Oral, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 103: Asia Pacific Acute Migraine Drugs Market, By Nasal, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 104: Asia Pacific Acute Migraine Drugs Market, By Other Routes of Administration, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 105: Asia Pacific Acute Migraine Drugs Market, By Over The Counter Availability, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 106: Asia Pacific Acute Migraine Drugs Market, By Prescription Availability, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 107: China Acute Migraine Drugs Market, By Value, 2018-2028 (USD Billion & CAGR)

Figure 108: China Acute Migraine Drugs Market Value, By Drug Type, 2021 (USD Billion)

Figure 109: China Acute Migraine Drugs Market Share, By Drug Type, By Value, 2021 (%)

Figure 110: China Acute Migraine Drugs Market Share, By Route of Administration, By Value, 2021 (%)

Figure 111: China Acute Migraine Drugs Market Share, By Availability, By Value, 2021 (%)

Figure 112: Japan Acute Migraine Drugs Market, By Value, 2018-2028 (USD Billion & CAGR)

Figure 113: Japan Acute Migraine Drugs Market Value, By Drug Type, 2021 (USD Billion)

Figure 114: Japan Acute Migraine Drugs Market Share, By Drug Type, By Value, 2021 (%)

Figure 115: Japan Acute Migraine Drugs Market Share, By Route of Administration, By Value, 2021 (%)

Figure 116: Japan Acute Migraine Drugs Market Share, By Availability, By Value, 2021 (%)

Figure 117: India Acute Migraine Drugs Market, By Value, 2018-2028 (USD Billion & CAGR)

Figure 118: India Acute Migraine Drugs Market Value, By Drug Type, 2021 (USD Billion)

Figure 119: India Acute Migraine Drugs Market Share, By Drug Type, By Value, 2021 (%)

Figure 120: India Acute Migraine Drugs Market Share, By Route of Administration, By Value, 2021 (%)

Figure 121: India Acute Migraine Drugs Market Share, By Availability, By Value, 2021 (%)

Figure 122: Rest of Asia Pacific Acute Migraine Drugs Market, By Value, 2018-2028 (USD Billion & CAGR)

Figure 123: Rest of Asia Pacific Acute Migraine Drugs Market Value, By Drug Type, 2021 (USD Billion)

Figure 124: Rest of Asia Pacific Acute Migraine Drugs Market Share, By Drug Type, By Value, 2021 (%)

Figure 125: Rest of Asia Pacific Acute Migraine Drugs Market Share, By Route of Administration, By Value, 2021 (%)

Figure 126: Rest of Asia Pacific Acute Migraine Drugs Market Share, By Availability, By Value, 2021 (%)

Figure 127: Middle East & Africa Acute Migraine Drugs Market Size, By Value, 2018H-2028F (USD Billion)

Figure 128: Middle East & Africa Acute Migraine Drugs Market Share, By Drug Type, 2021 (%)

Figure 129: Middle East & Africa Acute Migraine Drugs Market, By Ergot Alkaloids, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 130: Middle East & Africa Acute Migraine Drugs Market, By Analgesics, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 131: Middle East & Africa Acute Migraine Drugs Market, By Triptans, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 132: Middle East & Africa Acute Acute Migraine Drugs Market, By Other Drug Types, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 133: Middle East & Africa Acute Acute Migraine Drugs Market, By Intravenous, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 134: Middle East & Africa Acute Acute Migraine Drugs Market, By Oral, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 135: Middle East & Africa Acute Acute Migraine Drugs Market, By Nasal, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 136: Middle East & Africa Acute Acute Migraine Drugs Market, By Other Routes of Administration, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 137: Middle East & Africa Acute Acute Migraine Drugs Market, By Over The Counter Availability, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 138: Middle East & Africa Acute Acute Migraine Drugs Market, By Prescription Availability, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 139: Global Impact of Drivers and Restraints

Figure 140: Market Share of Prominent Companies of Acute Migraine Drugs, 2021 (%)

Figure 141: Eli Lilly and Company Revenues, 2019-2021 (USD Million)

Figure 142: Eli Lilly and Company Revenues Revenue , By Business Segments, 2021 (%)

Figure 143: Eli Lilly and Company Revenues Revenue , By Business Segments, 2021 (%)

Figure 144: GSK plc. Revenues, 2019-2021 (USD Million)

Figure 145: GSK plc. Revenue , By Business Segments, 2021 (%)

Figure 146: GSK plc. Revenue , By Geographical Segments, 2021 (%)

Figure 147: Bayer AG . Revenues, 2019-2021 (USD Million)

Figure 148: Bayer AG . Revenue , By Business Segments, 2021 (%)

Figure 149: Bayer AG . Revenue , By Geographical; Segments, 2021 (%)

Figure 150: J&J Revenues, 2019-2021 (USD Million)

Figure 151: J&J Revenue , By Business Segments, 2021 (%)

Figure 152: JJ&J Revenue , By Geographical Segments, 2021 (%)

Figure 153: Teva Pharmaceuticals Revenues, 2019-2021 (USD Million)

Figure 154: Teva Pharmaceuticals Revenue , By Geographical Segments, 2021 (%)

Figure 155: AbbVie Inc. Revenues, 2019-2021 (USD Million)

Figure 156: AbbVie Inc. Revenue , Product Sales by Product Segment, 2021 (%)

Figure 157: AbbVie Inc. Revenue , By Geographical Segments, 2021 (%)

Figure 158: Novartis Revenues, 2019-2021 (USD million)

Figure 159: Novartis Revenue , By Business Segments, 2021 (%)

Figure 160: Novartis Revenue , By Geographical Segments, 2021 (%)

Figure 161: Merck & Co., Inc. Revenues, 2019-2021 (USD Million)

Figure 162: Merck & Co., Inc. Revenue , By Geographic segment, 2021 (%)

Figure 163: Merck & Co., Inc. Revenue , By Business Segments, 2021 (%)

Figure 164: Pfizer Inc. Revenues, 2019-2021 (USD Million)

Figure 165: Pfizer Inc. Revenue , By Business Segments- By Products, 2021 (%)

Figure 166: Pfizer Inc. Revenue , By Geographic Segments, 2021 (%)

Figure 167: Boehringer Ingelheim Revenues, 2019-2021 (USD Million)

Figure 168: Boehringer Ingelheim Revenue , By Business Segments- By Products, 2021 (%)

Figure 169: Boehringer Ingelheim Revenue , By Geographical Segments, 2021 (%)



List of Tables

Table A1: Global Impact of Macro Economic Factors, By Region

Table A2: Acute Migraine Drugs in Pipeline

Table A3: United States Acute Migraine Drugs Market, By Drug Type, By Value, 2018-2021 (USD Billion)

Table A4: United States Acute Migraine Drugs Market, By Drug Type, By Value, 2022-2028 (USD Billion)

Table A5: United States Acute Migraine Drugs Market, By Route of Administration, By Value, 2018-2021 (USD Billion)

Table A6: United States Acute Migraine Drugs Market, By Route of Administration, By Value, 2022-2028 (USD Billion)

Table A7: United States Acute Migraine Drugs Market, By Availability, By Value, 2018-2021 (USD Billion)

Table A8: United States Acute Migraine Drugs Market, By Availability, By Value, 2022-2028 (USD Billion)

Table A9: Canada Acute Migraine Drugs Market, By Drug Type, By Value, 2018-2021 (USD Billion)

Table A10: Canada Acute Migraine Drugs Market, By Drug Type, By Value, 2022-2028 (USD Billion)

Table A11: Canada Acute Migraine Drugs Market, By Route of Administration, By Value, 2018-2021 (USD Billion)

Table A12: Canada Acute Migraine Drugs Market, By Route of Administration, By Value, 2022-2028 (USD Billion)

Table A13: Canada Acute Migraine Drugs Market, By Availability, By Value, 2018-2021 (USD Billion)

Table A14: Canada Acute Migraine Drugs Market, By Availability, By Value, 2022-2028 (USD Billion)

Table A15: Rest of Americas Acute Migraine Drugs Market, By Drug Type, By Value, 2018-2021 (USD Billion)

Table A16: Rest of Americas Acute Migraine Drugs Market, By Drug Type, By Value, 2022-2028 (USD Billion)

Table A17: Rest of Americas Acute Migraine Drugs Market, By Route of Administration, By Value, 2018-2021 (USD Billion)

Table A18: Rest of Americas Acute Migraine Drugs Market, By Route of Administration, By Value, 2022-2028 (USD Billion)

Table A19: Rest of Americas Acute Migraine Drugs Market, By Availability, By Value, 2018-2021 (USD Billion)

Table A20: Rest of Americas Acute Migraine Drugs Market, By Availability, By Value, 2022-2028 (USD Billion)

Table A21: Germany Acute Migraine Drugs Market, By Drug Type, By Value, 2018-2021 (USD Billion)

Table A22: Germany Acute Migraine Drugs Market, By Drug Type, By Value, 2022-2028 (USD Billion)

Table A23: Germany Acute Migraine Drugs Market, By Route of Administration, By Value, 2018-2021 (USD Billion)

Table A24: Germany Acute Migraine Drugs Market, By Route of Administration, By Value, 2022-2028 (USD Billion)

Table A25: Germany Acute Migraine Drugs Market, By Availability, By Value, 2018-2021 (USD Billion)

Table A26: Germany Acute Migraine Drugs Market, By Availability, By Value, 2022-2028 (USD Billion)

Table A27: United Kingdom Acute Migraine Drugs Market, By Drug Type, By Value, 2018-2021 (USD Billion)

Table A28: United Kingdom Acute Migraine Drugs Market, By Drug Type, By Value, 2022-2028 (USD Billion)

Table A29: United Kingdom Acute Migraine Drugs Market, By Route of Administration, By Value, 2018-2021 (USD Billion)

Table A30: United Kingdom Acute Migraine Drugs Market, By Route of Administration, By Value, 2022-2028 (USD Billion)

Table A31: United Kingdom Acute Migraine Drugs Market, By Availability, By Value, 2018-2021 (USD Billion)

Table A32: United Kingdom Acute Migraine Drugs Market, By Availability, By Value, 2022-2028 (USD Billion)

Table A33: France Acute Migraine Drugs Market, By Drug Type, By Value, 2018-2021 (USD Billion)

Table A34: France Acute Migraine Drugs Market, By Drug Type, By Value, 2022-2028 (USD Billion)

Table A35: France Acute Migraine Drugs Market, By Route of Administration, By Value, 2018-2021 (USD Billion)

Table A36: France Acute Migraine Drugs Market, By Route of Administration, By Value, 2022-2028 (USD Billion)

Table A37: France Acute Migraine Drugs Market, By Availability, By Value, 2018-2021 (USD Billion)

Table A38: France Acute Migraine Drugs Market, By Availability, By Value, 2022-2028 (USD Billion)

Table A39: Italy Acute Migraine Drugs Market, By Drug Type, By Value, 2018-2021 (USD Billion)

Table A40: Italy Acute Migraine Drugs Market, By Drug Type, By Value, 2022-2028 (USD Billion)

Table A41: Italy Acute Migraine Drugs Market, By Route of Administration, By Value, 2018-2021 (USD Billion)

Table A42: Italy Acute Migraine Drugs Market, By Route of Administration, By Value, 2022-2028 (USD Billion)

Table A43: Italy Acute Migraine Drugs Market, By Availability, By Value, 2018-2021 (USD Billion)

Table A44: Italy Acute Migraine Drugs Market, By Availability, By Value, 2022-2028 (USD Billion)

Table A45: Spain Acute Migraine Drugs Market, By Drug Type, By Value, 2018-2021 (USD Billion)

Table A46: Spain Acute Migraine Drugs Market, By Drug Type, By Value, 2022-2028 (USD Billion)

Table A47: Spain Acute Migraine Drugs Market, By Route of Administration, By Value, 2018-2021 (USD Billion)

Table A48: Spain Acute Migraine Drugs Market, By Route of Administration, By Value, 2022-2028 (USD Billion)

Table A49: Spain Acute Migraine Drugs Market, By Availability, By Value, 2018-2021 (USD Billion)

Table A50: Spain Acute Migraine Drugs Market, By Availability, By Value, 2022-2028 (USD Billion)

Table A51: Rest of Europe Acute Migraine Drugs Market, By Drug Type, By Value, 2018-2021 (USD Billion)

Table A52: Rest of Europe Acute Migraine Drugs Market, By Drug Type, By Value, 2022-2028 (USD Billion)

Table A53: Rest of Europe Acute Migraine Drugs Market, By Route of Administration, By Value, 2018-2021 (USD Billion)

Table A54: Rest of Europe Acute Migraine Drugs Market, By Route of Administration, By Value, 2022-2028 (USD Billion)

Table A55: Rest of Europe Acute Migraine Drugs Market, By Availability, By Value, 2018-2021 (USD Billion)

Table A56: Rest of Europe Acute Migraine Drugs Market, By Availability, By Value, 2022-2028 (USD Billion)

Table A57: China Acute Migraine Drugs Market, By Drug Type, By Value, 2018-2021 (USD Billion)

Table A58: China Acute Migraine Drugs Market, By Drug Type, By Value, 2022-2028 (USD Billion)

Table A59: China Acute Migraine Drugs Market, By Route of Administration, By Value, 2018-2021 (USD Billion)

Table A60: China Acute Migraine Drugs Market, By Route of Administration, By Value, 2022-2028 (USD Billion)

Table A61: China Acute Migraine Drugs Market, By Availability, By Value, 2018-2021 (USD Billion)

Table A62: China Acute Migraine Drugs Market, By Availability, By Value, 2022-2028 (USD Billion)

Table A63: Japan Acute Migraine Drugs Market, By Drug Type, By Value, 2018-2021 (USD Billion)

Table A64: Japan Acute Migraine Drugs Market, By Drug Type, By Value, 2022-2028 (USD Billion)

Table A65: Japan Acute Migraine Drugs Market, By Route of Administration, By Value, 2018-2021 (USD Billion)

Table A66: Japan Acute Migraine Drugs Market, By Route of Administration, By Value, 2022-2028 (USD Billion)

Table A67: Japan Acute Migraine Drugs Market, By Availability, By Value, 2018-2021 (USD Billion)

Table A68: Japan Acute Migraine Drugs Market, By Availability, By Value, 2022-2028 (USD Billion)

Table A69: India Acute Migraine Drugs Market, By Drug Type, By Value, 2018-2021 (USD Billion)

Table A70: India Acute Migraine Drugs Market, By Drug Type, By Value, 2022-2028 (USD Billion)

Table A71: India Acute Migraine Drugs Market, By Route of Administration, By Value, 2018-2021 (USD Billion)

Table A72: India Acute Migraine Drugs Market, By Route of Administration, By Value, 2022-2028 (USD Billion)

Table A73: India Acute Migraine Drugs Market, By Availability, By Value, 2018-2021 (USD Billion)

Table A74: India Acute Migraine Drugs Market, By Availability, By Value, 2022-2028 (USD Billion)

Table A75: Rest of Asia Pacific Acute Migraine Drugs Market, By Drug Type, By Value, 2018-2021 (USD Billion)

Table A76: Rest of Asia Pacific Acute Migraine Drugs Market, By Drug Type, By Value, 2022-2028 (USD Billion)

Table A77: Rest of Asia Pacific Acute Migraine Drugs Market, By Route of Administration, By Value, 2018-2021 (USD Billion)

Table A78: Rest of Asia Pacific Acute Migraine Drugs Market, By Route of Administration, By Value, 2022-2028 (USD Billion)

Table A79: Rest of Asia Pacific Acute Migraine Drugs Market, By Availability, By Value, 2018-2021 (USD Billion)

Table A80: Rest of Asia Pacific Acute Migraine Drugs Market, By Availability, By Value, 2022-2028 (USD Billion)

Table A81: Eli Lilly and Company Financials, 2019-2021

Table A82: GSK plc. Financials, 2019-2021

Table A83: Bayer AG Financials, 2019-2021

Table A84: Johnson & Johnson Financials, 2019-2021

Table A85: Teva Pharmaceuticals Financials, 2019-2021

Table A86: AbbVie Inc. Financials, 2019-2021

Table A87: Novartis Financials, 2019-2021

Table A88: Merck & Co., Inc. Financials, 2019-2021

Table A89: Pfizer Inc. Financials, 2019-2021

Table A90: Boehringer Ingelheim Financials, 2019-2021